Found 6 articles for: "Urticaria"
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
April 2026 | Volume 25 | Issue 4 | Original Article | 311 | Copyright © April 2026
Objective: Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. Several cytokines have been linked to CSU...
Read MoreThe Heat Is On: A Review of Heat-Induced Dermatoses
July 2025 | Volume 24 | Issue 7 | Features | 725 | Copyright © July 2025
Clinical Impacts of Omalizumab on the Psychiatric Comorbidities of Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
April 2024 | Volume 23 | Issue 4 | Editorials | e116 | Copyright © April 2024
Urticaria Pigmentosa Without Pruritus
March 2024 | Volume 23 | Issue 3 | Case Reports | e81 | Copyright © March 2024
Mastocytosis is a group of disorders characterized by the pathologic accumulation of mast cells in various tissues. One example of mastocytosis is urticaria pigmentosa, which presents with mastoc...
Read MoreDrugs in Development for Chronic Spontaneous Urticaria
April 2023 | Volume 22 | Issue 4 | Original Article | 393 | Copyright © April 2023
Background: Chronic spontaneous urticaria (CSU) is a debilitating disease for which many patients are inadequately treated. However, recent advancements in our understanding of t...
Read MoreLong-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis
October 2022 | Volume 21 | Issue 10 | Case Reports | 1124 | Copyright © October 2022
Normocomplementemic urticarial vasculitis is a rare autoimmune disorder characterized by leukocytoclasia, fibrin deposits, and extravasated erythrocytes affecting multiple organ systems. Current treat...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.